Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0850
+0.0030 (3.66%)
Jul 31, 2026, 4:10 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 89.38 million as of July 31, 2026. Its market cap has increased by 146.63% in one year.
Market Cap
89.38M
Enterprise Value
79.88M
Revenue
4.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 89.38M, an increase of 1,461.33%. That is a compound annual growth rate of 10.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 89.38M | 1.19% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 118.54M |
| Island Pharmaceuticals | 115.41M |
| Recce Pharmaceuticals | 110.80M |
| Paradigm Biopharmaceuticals | 98.01M |
| LTR Pharma | 84.53M |
| Avecho Biotechnology | 72.78M |
| Arovella Therapeutics | 72.53M |
| Immutep | 67.79M |